Achaogen, Inc. AKAO Cash Flow

Achaogen, inc. (AKAO)

CashFlow / TTM

Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Net loss
-	-	0	-139,588	-	-	-100,090	-92,289	-71,227	-52,769	-50,493	-33,111	-27,093	-20,681	-20,231	-22,900	-20,176	-17,808	-12,059	-12,814	-13,112	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
-	-	-	1,782	-	-	-	433	441	449	452	448	426	405	387	369	358	354	359	414	506	0	0	0
Amortization of (discount) premium on short-term investments
341	413	412	282	227	118	13	-102	-304	-445	-473	-493	-500	-477	-536	-424	-257	0	0	0	-	-	-	-
Stock-based compensation expense
14,410	15,691	16,378	15,506	14,172	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	-	-	0	0	3,049	-	2,862	2,675	2,444	2,050	1,701	1,380	1,096	1,053	0	0	0
Change in warrant and derivative liabilities
-	-	-	-14,353	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on debt extinguishment
-819	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revaluation of convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	0	0
Change in derivative liability
-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-
Non-cash interest expense relating to notes payable
862	606	674	737	847	899	882	813	741	612	581	437	302	171	0	137	209	303	415	404	472	0	0	0
Non-cash interest expense relating to related-party convertible loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197	0	0	0
Non-cash restructuring charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Change in operating assets and liabilities:
Contracts receivable
-	-	0	-4,077	-	-	-7,535	800	7,112	10,989	4,163	594	-195	86	-787	-1,555	-1,996	-597	-886	1,163	2,972	0	0	0
Prepaids and other assets
-4,955	0	0	-126	-	-	5,239	5,619	199	336	1,653	2,864	1,504	1,321	230	348	-1,397	495	378	-119	1,456	0	0	0
Other long-term assets
9,190	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued liabilities
691	7,420	12,544	986	5,736	-4,146	-1,147	5,440	6,668	9,860	8,283	4,807	3,076	-232	2,190	1,063	-539	3,271	-792	1,486	1,450	0	0	0
Deferred revenue
-2,100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
3,832	3,466	2,951	2,871	1,588	695	193	-269	-225	-61	-49	-14	8	-9	122	95	123	144	-37	13	-198	0	0	0
Cash flows from investing activities:
Net cash used in operating activities
-	-	-	-128,549	-	-	-	-51,455	-46,903	-46,473	-41,968	-27,318	-21,088	-18,407	-13,764	-17,161	-14,283	-11,768	-10,116	-10,339	-13,854	0	0	0
Purchase of property and equipment
9,036	10,225	9,179	7,242	7,106	5,744	3,805	1,817	901	619	545	853	606	579	674	355	340	172	92	104	110	0	0	0
Purchase of short-term investments
58,101	58,101	84,558	84,094	121,796	0	0	0	-	-	-	39,854	41,851	51,364	47,084	47,084	45,087	0	0	0	-	-	-	-
Maturities of short-term investments
78,014	120,678	134,061	129,714	129,370	88,106	52,741	53,206	42,230	45,295	45,760	48,026	47,689	0	0	0	-	0	0	0	-	-	-	-
Cash flows from financing activities:
Net cash used in investing activities
-	-	-	38,378	-	-	-	-66,331	10,368	15,017	5,361	7,319	5,232	-11,319	-22,934	-39,496	-45,427	-25,398	-92	-104	-110	0	0	0
Proceeds from issuance of convertible preferred stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,200	0	0	0
Proceeds from sales of common stock, net of issuance costs
31,416	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Payments of issuance costs, related to underwritten public offering
-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the issuance of common stock in connection with equity incentive plans
2,995	3,924	2,781	2,572	2,968	2,074	2,002	1,001	466	351	379	589	1,353	0	0	0	-	-	-	-	-	-	-	-
Proceeds from exercise of stock warrants
-	-	-	-	418	0	0	0	-	-	-	-	-	-	-	-	2	0	0	0	-	-	-	-
Proceeds from loan payable, net of issuance costs
49,189	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of loan payable
22,833	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options, net of repurchases
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0
Repayment of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,896	8,090	9,259	4,728	4,632	0	0	0
Net cash provided by financing activities
-	-	-	155,370	-	-	-	136,243	135,462	38,446	51,708	16,498	17,262	17,856	1,750	-5,347	67,853	75,886	74,878	82,244	17,629	0	0	0
Net increase in cash, cash equivalents, and restricted cash
-	-	-	65,200	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of cash flow information
Interest paid
-	-	-	2,016	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	38,720	64,670	71,801	3,665	0	0	0
Supplemental disclosures of noncash investing and financing information
Conversion of convertible preferred stock into common stock
-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	132,278	0	0	0	-	-	-	-
Reclassification of warrant liability to additional paid-in capital
-	-	-	-	2,088	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment included in deferred rent
-	-	-	-	4,701	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property plant and equipment included in accounts payable and accrued expenses
-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of warrant liability to additional paid-in-capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Deferred initial public offering issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Conversion of related-party convertible loan and notes payable to convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,724	0	0	0
Reclassification of warrant liability to additional paid-in capital
-	-	-	-	2,088	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-